The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim

被引:15
|
作者
Morton, JAP [1 ]
Baker, DP [1 ]
Hutchins, CJ [1 ]
Durrant, STS [1 ]
机构
[1] ROYAL BRISBANE HOSP,BONE MARROW TRANSPLANT UNIT,HERSTON,QLD 4209,AUSTRALIA
关键词
D O I
10.1046/j.1537-2995.1997.37697335158.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Peripheral blood is rapidly replacing bone marrow as a source of hematopoietic progenitor cells for autologous transplantation. The advantages of peripheral blood progenitor cell transplantation are enhanced by the ability to collect sufficient progenitor cells to ensure rapid neutrophil and platelet recovery in a single procedure on some cell separators. STUDY DESIGN AND METHODS: A prospective randomized study was undertaken to compare peripheral blood progenitor cell yields from two cell separators (MCS-3P, Haemonetics and Spectra, COBE). Fifteen consecutive patients were mobilized with cyclophosphamide 2 g per m(2) (Day 0) and filgrastim 10 mu g per kg (Days 1-11). Consecutive collections (Day 10, Day 11) were performed with each machine once; patients were randomly assigned to either machine for the initial collection. RESULTS: Collection time was longer on the MCS-3P (p = 0.001), and the volume processed was greater with the Spectra (p<0.0001). Despite similar nucleated cell yield (p = 0.62), the yield of CD34(+) cells (p = 0.001) and colony-forming units-granulocytic-monocytic (p = 0.0001) was significantly higher with the Spectra. The yield of nucleated cells per unit of blood volume processed was higher for the MCS-3P (p = 0.0007), while the CD34+ cell yield (p = 1) and colony-forming units-granulocytic-monocytic yield (p = 1) per unit of blood volume processed were similar for the two machines. The collection of CD34+ cells at levels >2 x 10(6) per kg (p = 0.063), 5 x 10(6) per kg (p = 0.031), and colony-forming units-granulocytic-monocytic >1 x 10(6) per kg (p = 0.25) after a single collection was superior for the Spectra. CONCLUSION: The yield of progenitor cells after collection on the Spectra was superior to that achieved with the MCS-3P, because of the larger volume of blood processed per procedure. This would permit more patients to undergo only one collection.
引用
收藏
页码:631 / 633
页数:3
相关论文
共 39 条
  • [21] Collection of Autologous Peripheral Blood Stem Cells Using the COBE Spectra Is Associated with Higher CD34+Yields and Requires Less Collection Time Than the Fresenius AS104 Cell Separator
    Potter, Grant W.
    LeMaistre, Charles F.
    Shaughnessy, Paul
    Islas, Miguel
    Huerta, Juan
    Bachier, Carlos
    BLOOD, 2009, 114 (22) : 848 - 848
  • [22] A combination of dexamethasone, cyclophosphamide, etoposide, and cisplatin is less toxic and more effective than high-dose cyclophosphamide for peripheral stem cell mobilization in multiple myeloma
    Corso, A
    Arcaini, L
    Caberlon, S
    Zappasodi, P
    Mangiacavalli, S
    Lorenzi, A
    Rusconi, C
    Troletti, D
    Maiocchi, MA
    Pascutto, C
    Morra, E
    Lazarino, M
    HAEMATOLOGICA, 2002, 87 (10) : 1041 - 1045
  • [23] A new separation protocol (DRBCP-F) for automatic blood component donation with the cell separator MCS 3p for collection of leukocyte-depleted red blood cell concentrates and plasma
    Zeiler, T
    Kretschmer, V
    TRANSFUSIONSMEDIZIN 1996/97, 1997, 34 : 118 - 122
  • [24] G-CSF dosage adjusted to neutrophil count might improve peripheral blood progenitor cell mobilization and be more cost-effective
    Faulkner, LB
    Tucci, F
    Tamburini, A
    Tintori, V
    Lippi, A
    Bambi, F
    Malentacca, E
    Genovese, F
    Bernini, G
    BLOOD, 1996, 88 (10) : 1572 - 1572
  • [25] Automated blood component collection with the MCS 3p cell separator: evaluation of three protocols for buffy coat-poor and white cell-reduced packed red cells and plasma
    Zeiler, TA
    Kretschmer, V
    TRANSFUSION, 1997, 37 (08) : 791 - 797
  • [26] G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective
    LB Faulkner
    F Tucci
    A Tamburini
    V Tintori
    AA Lippi
    F Bambi
    F Malentacca
    C Azzari
    AMG Gelli
    F Genovese
    G Bernini
    Bone Marrow Transplantation, 1998, 21 : 1091 - 1095
  • [27] G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective
    Faulkner, LB
    Tucci, F
    Tamburini, A
    Tintori, V
    Lippi, AA
    Bambi, F
    Malentacca, F
    Azzari, C
    Gelli, AMG
    Genovese, F
    Bernini, G
    BONE MARROW TRANSPLANTATION, 1998, 21 (11) : 1091 - 1095
  • [28] Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients
    P Quittet
    P Ceballos
    E Lopez
    Z Y Lu
    P Latry
    C Becht
    E Legouffe
    N Fegueux
    C Exbrayat
    D Pouessel
    V Rouillé
    J P Daures
    B Klein
    J F Rossi
    Bone Marrow Transplantation, 2006, 38 : 275 - 284
  • [29] Prospective study of timing for autologous stem cell collection:: Harvest initiated on the day with 5/mm3 or more of peripheral blood hematopoietic progenitor cell counts enumerated by the Sysmex SE-9000™.
    Kim, S
    Kim, EK
    Park, JS
    Kang, BJ
    Kim, SE
    Sohn, HJ
    Park, S
    Kim, MW
    Lee, J
    Chi, HS
    Park, CJ
    Suh, C
    BLOOD, 2003, 102 (11) : 957A - 958A
  • [30] Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4g/m2) enhance the peripheral blood progenitor cell harvest:: results of two randomized studies including 120 patients
    Quittet, P.
    Ceballos, P.
    Lopez, E.
    Lu, Z. Y.
    Latry, P.
    Becht, C.
    Legouffe, E.
    Fegueux, N.
    Exbrayat, C.
    Pouessel, D.
    Rouille, V.
    Daures, J. P.
    Klein, B.
    Rossi, J. F.
    BONE MARROW TRANSPLANTATION, 2006, 38 (04) : 275 - 284